Related references
Note: Only part of the references are listed.Clinical trials of transcatheter aortic valve replacement
Karim Al-Azizi et al.
HEART (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease
John Pirault et al.
FRONTIERS IN PHARMACOLOGY (2018)
Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia
Gonzalo Artiach et al.
FRONTIERS IN PHARMACOLOGY (2018)
Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment
Rita Kleinauskiene et al.
MEDICINA-LITHUANIA (2018)
2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Helmut Baumgartner et al.
EUROPEAN HEART JOURNAL (2017)
The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome
Yan Huang et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Eicosapentaenoic acid prevents arterial calcification in klotho mutant mice
Kazufumi Nakamura et al.
PLOS ONE (2017)
Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics
Justin T. English et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2017)
Low salivary resolvin D1 to leukotriene B4 ratio predicts carotid intima media thickness: A novel biomarker of non-resolving vascular inflammation
Silke Thul et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
Lipid Mediators in the Resolution of Inflammation
Charles N. Serhan et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Long chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in Japanese men in Japan and white men in the USA: population based prospective cohort study
Akira Sekikawa et al.
HEART (2014)
Biomechanical factors in the biology of aortic wall and aortic valve diseases
Magnus Back et al.
CARDIOVASCULAR RESEARCH (2013)
Upregulation of the 5-Lipoxygenase Pathway in Human Aortic Valves Correlates With Severity of Stenosis and Leads to Leukotriene-Induced Effects on Valvular Myofibroblasts
Edit Nagy et al.
CIRCULATION (2011)
Micrometric molecular histology of lipids by mass spectrometry imaging
David Touboul et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2011)
ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model
Mikko A. Simolin et al.
BMC CARDIOVASCULAR DISORDERS (2009)
Lowering Plasma Cholesterol Levels Halts Progression of Aortic Valve Disease in Mice
Jordan D. Miller et al.
CIRCULATION (2009)
Cardiovascular risk and the omega-3 index
Clemens Von Schacky et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2007)
Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease
Elena Aikawa et al.
CIRCULATION (2007)
Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis
Christian A. Hudert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis
SJ Cowell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
